Development of cancer prognostic signature based on pan-cancer proteomics

Utilizing genomic data to predict cancer prognosis was insufficient. Proteomics can improve our understanding of the etiology and progression of cancer and improve the assessment of cancer prognosis. And the Clinical Proteomic Tumor Analysis Consortium (CPTAC) has generated extensive proteomics data...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Weiguo, Chen, Jianhui, Weng, Wanqing, Xiang, Yukai, Shi, Hongqi, Shan, Yunfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291886/
https://www.ncbi.nlm.nih.gov/pubmed/33200655
http://dx.doi.org/10.1080/21655979.2020.1847398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291886/
https://www.ncbi.nlm.nih.gov/pubmed/33200655
http://dx.doi.org/10.1080/21655979.2020.1847398

Ejemplares similares